arrow
J

Jeanette K. Doorduijn

erasmus mc cancer institute
H指数:34
被引数:6,358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

非侵入性基因分型及早期疾病动态变化表明,在TRIANGLE试验中接受治疗的套细胞淋巴瘤患者中,伊布替尼联合免疫化疗的疗效。

Leukemia
IF13.4
2025-11-030
OAAI
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA–EU MCL网络关于套细胞淋巴瘤诊断与治疗指南

2025-10-220
OAAI
Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies
2024-12-010
PRE
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project

利妥昔单抗维持治疗联合含伊布替尼方案(含或不含ASCT)对年轻、初治套细胞淋巴瘤患者的影响:一项来自Multiply项目嵌入Triangle数据集的分析

BLOOD
IF23.1
2024-11-053
PRE
Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

自体干细胞移植在含伊布替尼的一线治疗背景下年轻套细胞淋巴瘤患者中的作用:欧洲MCL网络随机Triangle试验结果

BLOOD
IF23.1
2024-11-051
PRE
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
LANCET
IF88.5
2024-05-0113
OAAI
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study
2023-12-011
OAAI
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
2023-07-2010
OAAI
Clinical Impact of Polymerase Chain Reaction-based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study
2023-03-1133
OAAI
The EHA Research Roadmap: Malignant Lymphoid Diseases

EHA研究路线图: 恶性淋巴疾病

2022-06-013
OAAI